Novo Nordisk
Amy Articolo is an experienced medical professional with a strong background in bariatric medicine and obesity treatment. Currently serving as the Lead Liver Health Unit and Medical Director for both NASH and Obesity/NASH at Novo Nordisk since June 2018, Amy has previously held leadership positions at the Obesity Treatment Foundation and Salvéo Weight Management, where emphasis was placed on advancing clinical research and providing chronic care for bariatric patients. Amy also contributed to educational revitalization as a board member for the Franklin Foundation for Innovation and practiced as an Obstetrician/Gynecologist at Garden State Ob/Gyn Associates. Academic qualifications include a Doctor of Osteopathy from the Philadelphia College of Osteopathic Medicine and dual Bachelor's Degrees in American History and English Literature from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Novo Nordisk
378 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.